The Annexure

News to 9 October 2026 ·

Desk›Financial Services› Blueblood Ventures Ltd

Blueblood Ventures Ltd

BSE 539637 · NSE BVL · ISIN INE562S01013 · Group M · Suspended

Financial Services › Financial Services › Finance › Other Financial Services

₹11.07

+4.93%

BSE close, 28 August 2026

Market cap

₹3.32 cr

0.3 cr shares · Micro cap

Free float

₹1.56 cr

as published

P/E · P/B

100.6× · —

EPS ₹0.11 · BV —

FY25-26 rev / PAT

0.79 / 0.03

₹ cr, as filed

Filings, window

11

1 selected · 9%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹11.07 52-WK HIGH ₹11.07
Against 52-week high+0.0%
Against 52-week low+0.0%
Day change+4.93%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹0.11
Price / earnings100.64×
Price / book—
Book value — derived, price ÷ P/B—
Return on equity—
Operating margin—
Net margin—

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Mar-26 · Q -0.22 -0.14 -0.46 — —
Sep-25 · Q 1.01 0.17 0.57 18.25% 16.87%
FY25-26 0.79 0.03 0.11 7.20% 4.17%

Quarter on quarter

Revenue, quarter on quarter
-121.8%
Net profit, quarter on quarter
-182.4%

Disclosure profile 11 filings in the window

0 median 16.0 sector max 100 11 23th percentile of 693 Financial Services filers
Shaded is the middle half of the sector, 12 to 23 filings. Measured against the 693 Financial Services companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Selected sub-total1
Procedural
AGM / EGM2
General2
Annual Report1
Board Meeting1
Book Closure1
Compliance Certificate1
Outcome1
Trading Window1
Procedural sub-total10
Total11

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group M, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

11 filings · 1 selected · busiest 2026-09-07

Filing rhythm · the twelve most recent

2026-09-072026-10-09

SelectedProcedural

Filings

11 in the window · 1 earlier on record

  1. 9 October 2026 ·

    General

    General Announcement- The Board Of Directors Of Blueblood Ventures Limited ('The Company'), At Its Meeting Held Today, I.E., Friday, 09 October 2026, At The Registered Office Of The Company, Has Considered And Approved The Following Matters: 1. Appointment Of Internal Auditor M/S. Mahesh Sharma & Associates, Chartered Accountants (Firm Registration No. 014330N), As The Internal Auditor Of The Company For The Financial Years 2026-27 To 2030-31. 2. The Appointment Of Mr. Chandrashekhar Singh (DIN: 05131693) As An Additional Director In The Category Of Non-Executive Independent Director Of The Company With Effect From 09 October 2026.3.Opening Of Branch Office At Kolkata. 4. Approved The Debt Assignment Transaction.

    The Board of Directors of Blueblood Verntures Limited("the Company") , at its meeting held today, i.e., Friday, 09 Octobeer 2026 at the registered office of the Company, has considered ....

    Company Update / General View filing →

  2. 9 October 2026 ·

    General

    Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), We Wish To Inform You That The Board Of Directors Of Blueblood Ventures Limited ('The Company'), At Its Meeting Held Today, I.E., Friday, 09 October 2026, At The Registered Office Of The Company, Has Considered And Approved The Following Matters: 1. Appointment Of Internal Auditor M/S. Mahesh Sharma & Associates, Chartered Accountants (Firm Registration No. 014330N), As The Internal Auditor Of The Company For The Financial Years 2026-27 To 2030-31. 2. The Appointment Of Mr. Chandrashekhar Singh (DIN: 05131693) As An Additional Director In The Category Of Non-Executive Independent Director Of The Company With Effect From 09 October 2026.3.Opening Of Branch Office At Kolkata. 4. Approved The Debt Assignment Transaction.

    The Board of Directors of Blueblood Ventures Limited("the company"), at its meeting held today i.e., Friday, 09 October 2026, at the registered office of the Company, has considered and ....

    Company Update / General View filing →

  3. 9 October 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On 09 October 2026.

    Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), We Wish To Inform You That The Board Of Directors Of ....

    Board Meeting / Outcome of Board Meeting View filing →

  4. 7 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Compliances Certificate under Reg. 74 (5) of SEBI(DP) Regulations, 2018 for the Quarter ended on 30th September, 2026

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  5. 30 September 2026 ·

    Board Meeting

    Board Meeting Intimation for The Appointment Of Internal Auditor And Mr. Chandrashekhar Singh As A Director Of The Company.

    Blueblood Ventures Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/10/2026 ,inter alia, to consider and approve for the appointment of Internal ....

    Board Meeting / Board Meeting View filing →

  6. 30 September 2026 ·

    Trading Window

    Closure of Trading Window

    Intimation of Closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

  7. 30 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Proceedings of 19th Annual General Meeting of the Blueblood Ventures Limited held on Wednesday, 30th September,2026 at 11:30 A.M.

    AGM/EGM / AGM View filing →

  8. 7 September 2026 ·

    AGM / EGM

    Notice Of The AGM Of The Company

    Blueblood Ventures Limited had informed the BSE that the Annual General Meeting of the Company will be held on Wednesday 30th September,2026

    AGM/EGM / AGM View filing →

  9. 7 September 2026 ·

    Book Closure

    Fixes Book Closure For AGM

    The Register of Member and Share transfer books of the Company will remain closed from Wenesday 23rd September,2026 to 30th September,2026 (both days inclusive)

    Corp. Action / Book Closure View filing →

  10. 7 September 2026 ·

    Outcome

    Board Meeting Outcome for Outcome Of Board Meeting

    This is to inform that the Board of Directors at their meeting held on Monday 07th September, 2026 has decided that Annual General Meeting of the Company will be held on Wednesday, the ....

    Others / Outcome without intimation View filing →

  11. 7 September 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Annual Report For the Financial Year ended 2025-206

    Others / Reg. 34 (1) Annual Report View filing →

RSS feed for Blueblood Ventures Ltd · the 50 most recent filings